HCWB
HCW Biologics Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.08
−6.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 23.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.33x
- Price / sales
- 0.36x
- Price / cash flow
- -0.20x
Enterprise value
- Enterprise value
- $8.2M
- EV / sales
- 1.23x
- EV / EBITDA
- -1.93x
- EV / EBIT
- -1.34x
- Market cap
- $2.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026